Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection
暂无分享,去创建一个
[1] M. Mizokami,et al. Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B , 1994, Digestive Diseases and Sciences.
[2] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. , 2003, The New England journal of medicine.
[3] H. Isom,et al. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro , 2003, Hepatology.
[4] S. Hadziyannis,et al. Course of virologic breakthroughs under long‐term lamivudine in HBeAg‐negative precore mutant HBV liver disease , 2002, Hepatology.
[5] R. Locksley,et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. , 2002, Immunity.
[6] M. Brunetto,et al. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. , 2002, Journal of hepatology.
[7] C. Chu,et al. Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion , 2002, Journal of Clinical Microbiology.
[8] S. Lee,et al. Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan , 2001, Journal of viral hepatitis.
[9] H. Will,et al. A dominant hepatitis B virus population defective in virus secretion because of several S‐gene mutations from a patient with fulminant hepatitis , 2001, Hepatology.
[10] S. Hadziyannis,et al. Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis B , 2001 .
[11] J. Hoofnagle,et al. Long‐term therapy of chronic hepatitis B with lamivudine , 2000, Hepatology.
[12] K. Koike,et al. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region , 2000, American Journal of Gastroenterology.
[13] M. Chen,et al. Nondeletional T-Cell Receptor Transgenic Mice: Model for the CD4+ T-Cell Repertoire in Chronic Hepatitis B Virus Infection , 2000, Journal of Virology.
[14] L. Solforosi,et al. Molecular Epidemiology of an Outbreak of Fulminant Hepatitis B , 2000, Journal of Clinical Microbiology.
[15] S. Günther,et al. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. , 2000, Virology.
[16] O. Yokosuka,et al. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses. , 2000, Journal of hepatology.
[17] Jian-She Wang,et al. Infection of the fetus with hepatitis B e antigen via the placenta , 2000, The Lancet.
[18] R. Purcell,et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection , 2000, Hepatology.
[19] L. Stuyver,et al. Three cases of severe subfulminant hepatitis in heart‐transplanted patients after nosocomial transmission of a mutant hepatitis B virus , 1999, Hepatology.
[20] J. Summers,et al. Enrichment of a Precore-Minus Mutant of Duck Hepatitis B Virus in Experimental Mixed Infections , 1999, Journal of Virology.
[21] H. Trübel,et al. Mutations in the basic core promotor and the precore region of hepatitis b virus and their selection in children with fulminant and chronic hepatitis B , 1999, Hepatology.
[22] M. Buti,et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. , 1999, Hepatology.
[23] H. Schlicht,et al. Differential antigen-processing pathways of the hepatitis B virus e and core proteins. , 1999, Gastroenterology.
[24] S. Günther,et al. Functional analysis of HBV genomes from patients with fulminant hepatitis , 1998, Hepatology.
[25] P. Wingfield,et al. Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens. , 1998, Journal of molecular biology.
[26] W. Zhai,et al. Experimental study on pathogenicity of precore mutants in Hepadnaviridae. , 1998, Chinese Medical Journal.
[27] K. Reifenberg,et al. The Hepatitis B Virus e Antigen Cannot Pass the Murine Placenta Efficiently and Does Not Induce CTL Immune Tolerance in H-2bMicein Utero , 1998 .
[28] M. Chen,et al. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. , 1998, Journal of immunology.
[29] K. Koike,et al. Precore wild‐type DNA and immune complexes persist in chronic hepatitis B after seroconversion: No association between genome conversion and seroconversion , 1998, Hepatology.
[30] M. Chen,et al. Role of B cells in antigen presentation of the hepatitis B core. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Morabito,et al. A randomized, controlled trial of a 24‐month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum , 1997, Hepatology.
[32] H. Tsubouchi,et al. Response to Interferon-α2a in Patients with e Antigen-negative Chronic Hepatitis B , 1997 .
[33] J. Quinn,et al. Transmission of a homogenous hepatitis B virus population of A1896‐containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult , 1997, Hepatology.
[34] M. Yaniv,et al. A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant‐transmitted fulminant hepatitis B , 1997, Hepatology.
[35] S. Chang,et al. Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens , 1997, Journal of virology.
[36] F. Schödel,et al. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype , 1997, Journal of virology.
[37] K. Moriyama,et al. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. , 1996, Virology.
[38] S. Günther,et al. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease , 1996, Journal of virology.
[39] T. Liang,et al. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. , 1996, The Journal of clinical investigation.
[40] F. Chisari,et al. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice , 1996, Journal of virology.
[41] M. Chen,et al. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication , 1996, Journal of virology.
[42] H. Will,et al. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation , 1996, Hepatology.
[43] F. Chisari,et al. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. , 1996, Journal of immunology.
[44] T. Baumert,et al. Precore mutants revisited , 1996, Hepatology.
[45] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[46] H. Okamoto,et al. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. , 1995, Kidney international.
[47] F. Weizsäcker,et al. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants , 1995, Journal of medical virology.
[48] M. Buti,et al. Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations , 1995, Hepatology.
[49] D. Persing,et al. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. , 1995, Gastroenterology.
[50] S. Wolf,et al. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[51] U. Spengler,et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection , 1995, Journal of virology.
[52] F. Schödel,et al. Characterization of self‐reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice , 1995, European journal of immunology.
[53] M. Loriot,et al. Low frequency of precore hepatitis B virus mutants in anti‐hepatitis B e—positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B , 1995, Hepatology.
[54] H. Okamoto,et al. Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis , 1995, Annals of Internal Medicine.
[55] P. Angus,et al. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation , 1995, Hepatology.
[56] F Tsuda,et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen , 1994, Journal of virology.
[57] G. Fattovich,et al. Interferon therapy for the anti-HBe positive form of chronic hepatitis B. , 1994, Antiviral research.
[58] S. Nagataki,et al. Changes in the prevalence of HBeAg‐negative mutant hepatitis B virus during the course of chronic hepatitis B , 1994, Hepatology.
[59] R. A. Crowther,et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy , 1994, Cell.
[60] A. Lok,et al. Detection of precore hepatitis B virus mutants in asymptomatic HBsAg‐positive family members , 1994, Hepatology.
[61] O. Yokosuka,et al. Coinfection study of precore mutant and wild‐type hepatitis B‐like virus in ducklings , 1994, Hepatology.
[62] M. Alter,et al. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. , 1994, The Journal of clinical investigation.
[63] F. Jirik,et al. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. , 1994, Journal of immunology.
[64] D. Persing,et al. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. , 1993, Gastroenterology.
[65] T. Maruyama,et al. Role of T-cell tolerance in the persistence of hepatitis B virus infection. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[66] T. Ishikawa,et al. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response. , 1993, Immunology.
[67] K. Koike,et al. Serology of acute exacerbation in chronic hepatitis B virus infection. , 1993, Gastroenterology.
[68] Q. Zhang,et al. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region , 1993, Journal of virology.
[69] H. Hsu,et al. Hepatitis B Virus in the Colostra of HBeAg‐Positive Carrier Mothers , 1993, Journal of pediatric gastroenterology and nutrition.
[70] H. Zentgraf,et al. Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis , 1993, Journal of virology.
[71] E. Tanzi,et al. Is the course of perinatal hepatitis B virus infection influenced by genetic heterogeneity of the virus? , 1993, Journal of medical virology.
[72] K. Koike,et al. The serology of chronic hepatitis B infection revisited. , 1993, The Journal of clinical investigation.
[73] R. Purcell,et al. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. , 1993, Virology.
[74] O. Yokosuka,et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. , 1993, The Journal of clinical investigation.
[75] H. Schlicht,et al. A cysteine and a hydrophobic sequence in the noncleaved portion of the pre-C leader peptide determine the biophysical properties of the secretory core protein (HBe protein) of human hepatitis B virus , 1992, Journal of virology.
[76] R. Purcell,et al. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host , 1992, Journal of virology.
[77] G. Dusheiko,et al. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon‐α , 1992, Hepatology.
[78] H. Hsu,et al. Cellular Immune Response to HBcAg in Mother‐to‐Infant Transmission of Hepatitis B Virus , 1992, Hepatology.
[79] M. Rugge,et al. A randomized controlled trial of lymphoblastoid interferon‐α in patients with chronic hepatitis B lacking HBeAg , 1992, Hepatology.
[80] S. Günther,et al. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. , 1992, Virology.
[81] M. Milella,et al. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. , 1992, Journal of hepatology.
[82] O. Yokosuka,et al. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. , 1992, The Journal of clinical investigation.
[83] J. Sung,et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.
[84] F. Chisari,et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[85] H. Thomas,et al. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis , 1991, Hepatology.
[86] J. Wands,et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.
[87] H. Will,et al. Mechanism, kinetics, and role of duck hepatitis B virus e-antigen expression in vivo. , 1991, Virology.
[88] H. Will,et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[89] H. Okamoto,et al. Hepatitis B Virus Mutants with Precore-Region Defects in Two Babies with Fulminant Hepatitis and Their Mothers Positive for Antibody to Hepatitis B e Antigen , 1991, Pediatric Research.
[90] H. Okamoto,et al. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti‐HBe induced spontaneously or with interferon therapy , 1990, Hepatology.
[91] A Valli,et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.
[92] H. Okamoto,et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. , 1990, Gastroenterology.
[93] J. Price,et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[94] F Tsuda,et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.
[95] R. Houghten,et al. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. , 1989, Journal of immunology.
[96] H. Schaller,et al. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus , 1989, Journal of virology.
[97] P. Wingfield,et al. Comparative immunogenicity of hepatitis B virus core and E antigens. , 1988, Journal of immunology.
[98] H. Schlicht,et al. The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation , 1987, Journal of virology.
[99] H. Varmus,et al. Expression of the precore region of an avian hepatitis B virus is not required for viral replication , 1987, Journal of virology.
[100] D. Milich,et al. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. , 1986, Science.
[101] Roger Williams,et al. FULMINANT HEPATITIS B IN SUCCESSIVE FEMALE SEXUAL PARTNERS OF TWO ANTI-HBe-POSITIVE MALES , 1986, The Lancet.
[102] M. Tong,et al. Prevention of maternal‐infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA , 1986, Hepatology.
[103] F. Callea,et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. , 1986, Gastroenterology.
[104] Kazuaki Takahashi,et al. Maternofetal Transmission of IgG-Bound Hepatitis B e Antigen , 1982, Pediatric Research.
[105] J. Squire,et al. SECOND THOUGHTS ON THE WILLINK REPORT , 1960 .